131 related articles for article (PubMed ID: 11687072)
1. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
Farquhar C; Lee O; Toomath R; Jepson R
Cochrane Database Syst Rev; 2001; (4):CD000194. PubMed ID: 11687072
[TBL] [Abstract][Full Text] [Related]
2. Statins for women with polycystic ovary syndrome not actively trying to conceive.
Xiong T; Fraison E; Kolibianaki E; Costello MF; Venetis C; Kostova EB
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD008565. PubMed ID: 37462232
[TBL] [Abstract][Full Text] [Related]
3. Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review.
Layton AM; Eady EA; Whitehouse H; Del Rosso JQ; Fedorowicz Z; van Zuuren EJ
Am J Clin Dermatol; 2017 Apr; 18(2):169-191. PubMed ID: 28155090
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome.
Ezeh U; Huang A; Landay M; Azziz R
J Womens Health (Larchmt); 2018 Jul; 27(7):892-902. PubMed ID: 29878857
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial.
Santer M; Lawrence M; Renz S; Eminton Z; Stuart B; Sach TH; Pyne S; Ridd MJ; Francis N; Soulsby I; Thomas K; Permyakova N; Little P; Muller I; Nuttall J; Griffiths G; Thomas KS; Layton AM;
BMJ; 2023 May; 381():e074349. PubMed ID: 37192767
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of Spironolactone for Adult Female Acne (SAFA): economic evaluation alongside a randomised controlled trial.
Pyne S; Sach TH; Lawrence M; Renz S; Eminton Z; Stuart B; Thomas KS; Francis N; Soulsby I; Thomas K; Permyakova NV; Ridd MJ; Little P; Muller I; Nuttall J; Griffiths G; Layton AM; Santer M
BMJ Open; 2023 Dec; 13(12):e073245. PubMed ID: 38081673
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of Topical Clascoterone versus systematic spironolactone for treatment of acne vulgaris: A systematic review and network meta-analysis.
Basendwh MA; Alharbi AA; Bukhamsin SA; Abdulwahab RA; Alaboud SA
PLoS One; 2024; 19(5):e0298155. PubMed ID: 38814916
[TBL] [Abstract][Full Text] [Related]
8. Spironolactone for acne in women.
Drug Ther Bull; 2023 Sep; 61(9):132. PubMed ID: 37468231
[No Abstract] [Full Text] [Related]
9. Spironolactone treatment for dermatologic indications is not associated with hypotension in a single-center retrospective study.
Hill RC; Wang Y; Shaikh B; Ong M; Christos PJ; Lipner SR
J Am Acad Dermatol; 2024 Jun; 90(6):1245-1247. PubMed ID: 38483433
[No Abstract] [Full Text] [Related]
10. No increased risk of breast or gynecologic malignancies in women exposed to spironolactone for dermatologic conditions: A retrospective cohort study.
Hill RC; Wang Y; Shaikh B; Lipner SR
J Am Acad Dermatol; 2024 Jun; 90(6):1302-1304. PubMed ID: 38423468
[No Abstract] [Full Text] [Related]
11. Effectiveness of spironolactone for women with acne vulgaris (SAFA) trial: a critically appraised topic.
Shields A; Barbieri JS
Br J Dermatol; 2023 Oct; 189(5):509-510. PubMed ID: 37503674
[No Abstract] [Full Text] [Related]
12. A Review of hormone-based therapies to treat adult acne vulgaris in women.
Trivedi MK; Shinkai K; Murase JE
Int J Womens Dermatol; 2017 Mar; 3(1):44-52. PubMed ID: 28492054
[TBL] [Abstract][Full Text] [Related]
13. Spironolactone for the treatment of acne in women, a retrospective study of 110 patients.
Charny JW; Choi JK; James WD
Int J Womens Dermatol; 2017 Jun; 3(2):111-115. PubMed ID: 28560306
[TBL] [Abstract][Full Text] [Related]
14. Factors that influence women's enrolment and ongoing participation in a partially decentralised randomised controlled dermatology trial: a qualitative interview study with participants in the SAFA (Spironolactone for Adult Female Acne) trial.
Boxall C; Renz S; Eminton Z; Nuttall J; Saji A; Cluff C; Wilcox C; Muller I; Layton AM; Soulsby I; Santer M
Trials; 2023 Oct; 24(1):661. PubMed ID: 37821899
[TBL] [Abstract][Full Text] [Related]
15. Clinico-investigative attributes of 122 patients with hirsutism: A 5-year retrospective study from India.
Mahajan VK; Singh Chauhan P; Chandel M; Singh Mehta K; Karan Singh V; Sharma A; Sharma R; Sharma J; Hooda S; Raj Verma Y; Sharma H
Int J Womens Dermatol; 2021 Jun; 7(3):237-242. PubMed ID: 34222577
[TBL] [Abstract][Full Text] [Related]
16. Use of oral contraceptives for management of acne vulgaris and hirsutism in women of reproductive and late reproductive age.
Słopień R; Milewska E; Rynio P; Męczekalski B
Prz Menopauzalny; 2018 Mar; 17(1):1-4. PubMed ID: 29725277
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the treatment of acne using radiofrequency techniques.
Zhang X; Zhou M; Liu Y; Zeng R
Lasers Med Sci; 2024 Mar; 39(1):92. PubMed ID: 38499897
[TBL] [Abstract][Full Text] [Related]
18. Modified ferriman-gallwey score and hirsutism among normal healthy female population.
Bibi S; Malik SE; Zeb S; Javed J
Pak J Med Sci; 2024; 40(3Part-II):332-336. PubMed ID: 38356815
[TBL] [Abstract][Full Text] [Related]
19. Problems in the reporting of acne clinical trials: a spot check from the 2009 Annual Evidence Update on Acne Vulgaris.
Ingram JR; Grindlay DJ; Williams HC
Trials; 2010 Jul; 11():77. PubMed ID: 20624287
[TBL] [Abstract][Full Text] [Related]
20. The Efficacy and Safety of Oral Spironolactone in the Treatment of Female Pattern Hair Loss: A Systematic Review and Meta-Analysis.
Aleissa M
Cureus; 2023 Aug; 15(8):e43559. PubMed ID: 37719557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
